Source: MarketScreener

Diversigen: Diversigen Inc. Selected by Nom Nom as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services

(marketscreener.com) ST. PAUL, Minn. and OAKLAND, Calif., May 22, 2020 -- Diversigen, Inc., a subsidiary of OraSure Technologies Inc. , and Nom Nom , a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will...https://www.marketscreener.com/ORASURE-TECHNOLOGIES-INC-10373/news/Diversigen-Inc-Selected-by-Nom-Nom-trade-as-the-Preferred-Provider-for-Metagenomics-and-Microbiom-30653697/?utm_medium=RSS&utm_content=20200522

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Caroline Popper's photo - Chairman & CEO of Diversigen, Inc.

Chairman & CEO

Caroline Popper

CEO Approval Rating

90/100

Read more